Radiation doses and fractionation schedules in non-low-risk ductal carcinoma in situ in the breast (BIG 3–07/TROG 07.01): a randomised, factorial, multicentre, open-label, phase 3 study

Long-Term Results of Hypofractionated Radiation Therapy for Breast Cancer

Timothy J. Whelan, Jean‐Philippe Pignol, Mark N. Levine et al. · New England Journal of Medicine · 2010 · 1.9K citations · Full text

Medicine, Oncology, Radiation Oncology +16

The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials

Joanne Haviland, John R. Owen, John Dewar et al. · The Lancet Oncology · 2013 · 1.5K citations · Full text

Medicine, Oncology, Radiation Oncology +17

Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial

Adrian Murray Brunt, Joanne Haviland, Duncan Wheatley et al. · The Lancet · 2020 · 1.1K citations · Full text

Medicine, Oncology, Surgery +17

Long-Term Outcomes of Invasive Ipsilateral Breast Tumor Recurrences After Lumpectomy in NSABP B-17 and B-24 Randomized Clinical Trials for DCIS

Irene Wapnir, James J. Dignam, Bernard Fisher et al. · JNCI Journal of the National Cancer Institute · 2011 · 780 citations · Full text

Medicine, Oncology, Surgery +12

Role of a 10-Gy boost in the conservative treatment of early breast cancer: results of a randomized clinical trial in Lyon, France.

P. Romestaing, Y Lehingue, C. Carrié et al. · Journal of Clinical Oncology · 1997 · 687 citations

Medicine, Oncology, Surgery +16